Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

2.8K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.8K
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

3.4K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.4K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

1.4K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.4K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

2.5K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.5K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

7.0K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
7.0K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.8K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Similar Sensorimotor Activations with and without Virtual Limbs During Action Execution and Observation in Neurorehabilitation Systems.

Brain topography·2026
Same author

Association between neoadjuvant paclitaxel dose intensity and outcomes in early triple-negative and HER2-positive breast cancer: a real-world data analysis.

ESMO real world data and digital oncology·2026
Same author

Cannabinoid-based Pharmacology for the Management of Substance Use Disorders.

Current topics in behavioral neurosciences·2025
Same author

In-Scanner Thoughts shape Resting-state Functional Connectivity: how participants "rest" matters.

bioRxiv : the preprint server for biology·2024
Same author

Alzheimer's disease and its treatment-yesterday, today, and tomorrow.

Frontiers in pharmacology·2024
Same author

Treatment of hypoplastic left heart syndrome: a systematic review and meta-analysis of randomised controlled trials.

Cardiology in the young·2023
Same journal

GABAergic neurons in medial prefrontal cortex and ventral hippocampus encode information about reward history in male mice.

Cell reports·2026
Same journal

Dynamicity of Topoisomerase 1 binding at super-enhancers regulates TLR-responsive gene expression program in macrophages.

Cell reports·2026
Same journal

Cadherin regulation of endoplasmic reticulum-plasma membrane contact sites.

Cell reports·2026
Same journal

Type I unconventional protein secretion of the SARS-CoV-2 nucleocapsid protein promotes inflammatory cytokine release.

Cell reports·2026
Same journal

Fibroblast MrgprX2/B2 signaling drives hypertrophic scar fibrosis.

Cell reports·2026
Same journal

Disrupted mitochondrial dynamics activate RNA-sensing innate immunity through mitochondrial RNA release.

Cell reports·2026
See all related articles

Related Experiment Video

Updated: Apr 25, 2026

Environmental Modulations of the Number of Midbrain Dopamine Neurons in Adult Mice
09:35

Environmental Modulations of the Number of Midbrain Dopamine Neurons in Adult Mice

Published on: January 20, 2015

8.3K

Midbrain endocannabinoids actuate dopamine-based action selection.

M Á Luján1, R Young-Morrison2, V Kashtelyan3

  • 1Department of Anatomy and Cell Biology, University of Illinois College of Medicine, Chicago, IL, USA; Department of Neurobiology, University of Maryland School of Medicine, Baltimore, MD, USA.

Cell Reports
|April 23, 2026
PubMed
Summary
This summary is machine-generated.

Midbrain endocannabinoid mobilization, specifically 2-arachidonoylglycerol (2-AG), is crucial for behavioral changes. This endocannabinoid signaling enables dopamine neurons to adapt actions based on environmental cues.

Keywords:
CP: neuroscienceavoidancecannabinoidsconditioningdopamineescapemidbrainmotivationpallidum

More Related Videos

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
09:54

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

25.3K
Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry
08:49

Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry

Published on: January 12, 2012

21.5K

Related Experiment Videos

Last Updated: Apr 25, 2026

Environmental Modulations of the Number of Midbrain Dopamine Neurons in Adult Mice
09:35

Environmental Modulations of the Number of Midbrain Dopamine Neurons in Adult Mice

Published on: January 20, 2015

8.3K
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
09:54

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

25.3K
Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry
08:49

Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry

Published on: January 12, 2012

21.5K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Behavioral Science

Background:

  • Adaptive behavior is essential for survival, relying on rapid responses to environmental changes.
  • Dopamine signaling in the brain reinforces reward-seeking and adverse outcome avoidance.
  • The precise molecular mechanisms governing dopamine's subsecond signaling for adaptive behavior are not fully understood.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying dopamine-mediated behavioral adaptation at subsecond timescales.
  • To determine the role of endocannabinoids in mediating dopamine neuron function and behavioral responses to cues.
  • To elucidate the necessity of endocannabinoid signaling for reward and punishment prediction.

Main Methods:

  • Utilized genetic manipulation to delete presynaptic cannabinoid type-1 receptors (CB1Rs).
  • Employed causal inference tools to analyze continuous brain signals.
  • Measured behavioral responses and dopaminergic activity in response to cues.

Main Results:

  • Midbrain endocannabinoid mobilization, particularly 2-arachidonoylglycerol (2-AG), is essential for cue-evoked behavioral invigoration.
  • Retrograde release of 2-AG from ventral tegmental area dopamine neurons is required for reward- and punishment-predictive signals.
  • Genetic deletion of CB1Rs mimicked behavioral and dopaminergic deficits, highlighting the 2-AG/CB1R pathway's importance.
  • 2-AG/CB1R communication is critical for striatal dopamine release in response to salient cues and conditioned responding.

Conclusions:

  • Endocannabinoid mobilization via 2-AG/CB1R signaling is a key molecular mechanism for adaptive action selection.
  • Dopamine neurons utilize an endocannabinoid-mediated disinhibition mechanism to control striatal dopamine release.
  • This pathway enables rapid, cue-informed behavioral adjustments crucial for survival.